May 10, 2002

UCSD Offers Clinical Trials for Patients
With Mental Health Disorders

Clinical trials for patients who suffer from depression, schizophrenia or post-traumatic stress disorder (PTSD) are offered by the Psychopharmacology Research Initiatives Center of Excellence at the University of California, San Diego (UCSD). Information is available by calling (619) 725-3527.

All patients enrolled in studies receive lab tests, physical exams, diagnostic evaluations and study medication at no charge. All trials provide monetary compensation for participation.

The study for depression is for persons age 18-80 who are currently on Prozac and still depressed. All patients in this study will be given active medication. At the conclusion of the study, participants will have the option to enter a continuation study where they will be on active medication (at no cost) for an additional 6 months.

Patients with symptoms of post-traumatic stress disorder (PTSD) are eligible for a study involving two medications. Individuals who enroll in the study have a one-in-three chance of receiving a placebo.

Two studies for persons with schizophrenia include one to treat daytime sleepiness in patients currently taking medications, and a second for individuals currently taking Zyprexa or Risperdal, who will have a 50 percent chance of receiving an additional medication. Patients with schizophrenia who are not on medications at this time are also needed for studies.

#  #  #

Media contact:
Sue Pondrom

UCSD Health Sciences Communications HealthBeat:

Directory of UCSD Clinical Studies Seeking Volunteers: